NOVELION THERAPEUTICS INC.·4

May 3, 4:01 PM ET

NOVELION THERAPEUTICS INC. 4

4 · NOVELION THERAPEUTICS INC. · Filed May 3, 2017

Insider Transaction Report

Form 4
Period: 2017-05-01
Chan Barbara Y
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-01+20,00020,000 total
    Exercise: $9.93Exp: 2027-05-01Common Shares (20,000 underlying)
Footnotes (2)
  • [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
  • [F2]Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 6,666 common shares underlying this stock option award will vest on May 1, 2018, 6,667 common shares underlying this stock option award will vest on May 1, 2019 and 6,667 common shares underlying this stock option award will vest on May 1, 2020.

Documents

1 file
  • 4
    a4.xmlPrimary

    4